Detalhe da pesquisa
1.
Antagonizing CD105 and androgen receptor to target stromal-epithelial interactions for clinical benefit.
Mol Ther
; 31(1): 78-89, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36045587
2.
Simulation study comparing analytical methods for single-item longitudinal patient-reported outcomes data.
Qual Life Res
; 32(3): 827-839, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36245019
3.
Cancer epithelia-derived mitochondrial DNA is a targetable initiator of a paracrine signaling loop that confers taxane resistance.
Proc Natl Acad Sci U S A
; 117(15): 8515-8523, 2020 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32238563
4.
A nonparametric Bayesian method for dose finding in drug combinations cancer trials.
Stat Med
; 41(6): 1059-1080, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35075652
5.
Nodal staging convergence for HPV- and HPV+ oropharyngeal carcinoma.
Cancer
; 127(10): 1590-1597, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33595897
6.
On the properties of the toxicity index and its statistical efficiency.
Stat Med
; 40(6): 1535-1552, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33345351
7.
Visualizing adverse events in clinical trials using correspondence analysis with R-package visae.
BMC Med Res Methodol
; 21(1): 244, 2021 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34753452
8.
A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors.
Pediatr Blood Cancer
; 67(4): e28134, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31876107
9.
A Bayesian seamless phase I-II trial design with two stages for cancer clinical trials with drug combinations.
Biom J
; 62(5): 1300-1314, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32150296
10.
Cancer phase I trial design using drug combinations when a fraction of dose limiting toxicities is attributable to one or more agents.
Biom J
; 61(2): 319-332, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29808507
11.
Development of a novel salivary gland cancer lymph node staging system.
Cancer
; 124(15): 3171-3180, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29742277
12.
Quantitative survival impact of composite treatment delays in head and neck cancer.
Cancer
; 124(15): 3154-3162, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29742280
13.
A Bayesian adaptive design for cancer phase I trials using a flexible range of doses.
J Biopharm Stat
; 28(3): 562-574, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28858566
14.
Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
Cancer
; 123(20): 3933-3942, 2017 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28640546
15.
Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
Cancer
; 123(9): 1555-1565, 2017 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28001302
16.
Combined high-intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base.
Cancer
; 123(23): 4583-4593, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28817183
17.
A Bayesian adaptive design for estimating the maximum tolerated dose curve using drug combinations in cancer phase I clinical trials.
Stat Med
; 36(2): 280-290, 2017 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27060889
18.
Plasma Glutamine as a Prognostic Biomarker in Localized Prostate Cancer: Comparison of Conventional Variables in Risk Stratification.
Oncology (Williston Park)
; 35(9): 528-535, 2021 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34524771
19.
Escalation with Overdose Control is More Efficient and Safer than Accelerated Titration for Dose Finding.
Entropy (Basel)
; 17(8): 5288-5303, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27156869
20.
Dose finding with drug combinations in cancer phase I clinical trials using conditional escalation with overdose control.
Stat Med
; 33(22): 3815-29, 2014 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-24825779